NCT00428064View on ClinicalTrials.gov

Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

May 31, 1998

Study Completion Date

June 30, 2004

Conditions
Renal Transplantation
Interventions
DRUG

Sirolimus

DRUG

cyclosporine

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00428064 - Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter